Five Prime Therapeutics Inc
-
Ticker
FPRX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in San Francisco, California
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ib clinical trials for the treatment of rheumatoid arthritis; and in pre-IND
…More stage for pigmented villonodular synovitis and multiple cancers in combination with nivolumab.
Five Prime Therapeutics Inc
Most Recent Responsibility Report
Our service enables potential investors to review the most recent and archived Five Prime Therapeutics Inc Sustainability Report, Five Prime Therapeutics Inc Corporate Social Responsibility Report, Five Prime Therapeutics Inc CSR Report, Five Prime Therapeutics Inc Corporate Responsibility, Five Prime Therapeutics Inc CR Report, Five Prime Therapeutics Inc Citizenship Report, Five Prime Therapeutics Inc ESG Report, and Five Prime Therapeutics Inc Environmental Report online.